Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1103501
                    [Title] => HPV vaccine does not induce lupus flares
                    [Summary] => 
The quadrivalent human papillomavirus vaccine is safe for patients with systemic lupus erythematosus and should be considered for women with inactive disease who receive stable doses of standard immunomodulatory therapy, according to data presented at the meeting.

                    [DatePublished] => 2013-08-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

NATIONAL ASSESSMENT

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1103501
                    [Title] => HPV vaccine does not induce lupus flares
                    [Summary] => 
The quadrivalent human papillomavirus vaccine is safe for patients with systemic lupus erythematosus and should be considered for women with inactive disease who receive stable doses of standard immunomodulatory therapy, according to data presented at the meeting.

                    [DatePublished] => 2013-08-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

HPV vaccine does not induce lupus flares

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | August 18, 2013 - 12:00am

The quadrivalent human papillomavirus vaccine is safe for patients with systemic lupus erythematosus and should be considered for women with inactive disease who receive stable doses of standard immunomodulatory...

Opinion